Colorectal cancer: The role of screening and surveillance

Journal of Investigative Medicine

Volumn 44, Issue 5, 1996, Pages 216-227

  Westergaard, Henrik ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLORECTAL TUMOR; GENETICS; HEALTH SURVEY; HUMAN; INCIDENCE; MASS SCREENING; PREVALENCE; REVIEW; RISK FACTOR; UNITED STATES;

COLORECTAL NEOPLASMS; HUMANS; INCIDENCE; MASS SCREENING; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 0030171090     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (104)

1. Wingo P, Tong T, Bolden S. Cancer statistics. CA Cancer J Clin 1995;45:8-30.
2. Winawer S, Zauber A, Ho M, O'Brien M, Gottlieb L. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
3. Lynch H, Smyrk T, Watson P, Lanspa S, Lynch J. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104:1535-49.
4. Rustgi A. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med 1994:331:1694-702.
5. Vasen H, Mecklin J-P, Khan P, Lynch H. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
6. Itzkowitz S, Kim Y. Polyps and benign neoplasms of the colon. In: Sleisenger M, Fordtran J, eds. Gastrointestinal disease. Philadelphia: WB Saunders; 1993:1402-29.
7. Maskens A. Histogenesis of adenomatous polyps in the human large intestine. Gastroenterology 1979;77:1245-51.
8. Morson B, Sobin L. Histologic typing of intestinal tumors. Geneva: World Health Organization, 1976.
9. Riddel R, Goldman H, Ransohoff D, Appleman H, Haggitt R. Dysplasia in inflammatory bowel diseases: standardized classification with provisional clinical application. Hum Pathol 1983;14:931-68.
10. O'Brien M, Winawer S, Zauber A, Gottlieb L, Sternberg S. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990;98:371-9.
11. Muto T, Bussey H, Morson B. The evolution of cancer of the colon and rectum. Cancer 1975;36:2251-70.
12. Vogelstein B, Fearon E, Hamilton S, Kern S, Preisinger A. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
13. Boland C, Sato J, Appleman H, Bresalier R, Feinberg A. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nature Medicine 1995;1:902-9.
14. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Josllyn G, Stevens J. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
15. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain S, Masiarz F, Polakis P, Munemitsu S. Association of the APC gene product with B-catenin. Science 1993;262:1731-3.
16. Su L-K, Vogelstein B, Kinzler K. Association of the APC tumor suppressor protein with catenins. Science 1993;262:1734-7.
17. Hinck L, Nathke I, Papkoff J, Nelson W. B-catenin: a common target for the regulation of cell adhesion by wnt-1 and src signaling pathways. Trends Biochem Sci 1994;19:538-42.
18. Collins J, Fleming T. Epithelial differentiation in the mouse preimplantation embryo: making adhesive cell cor tacts for the first time. Trends Biochem Sci 1995;20:307-12.
19. Moodie S, Wolfman A. The 3Rs of life: ras, raf and growth regulation. Trends Genet 1994;10:44-8.
20. Powell S, Zilz N, Bryan T, Hamilton S, Thibodeau S, Vogelstein B, Kinzler K. APC Mutations occur early during colorectal tumorigenesis. Nature 1992;359:235-7.
21. Enoch T, Norbury C. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p:53 and ATM. Trends Biochem Sci 1995;20:426-30.
22. Peltomaki P, Aaltonen L, Sistonen P, Pylkkanen L, Jarvinen H, Green J, Jass J, Weber J, Leach F. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-2.
23. Aaltonen L, Peltomaki P, Leach F, Sistenen P, Pylkkanen L, Powell S, Jen J, Hamilton S. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
24. Thibodeau S, Schaid D, Bren G. Microsatllite instability in cancer of the proximal colon. Science 1993;260:816-9.
25. Senior R. Stalking the start of colon cancer. Science 1994;263:1559-60.
26. Chung D, Rustgi A. DNA mismatch repair and cancer. Gastroenterology 1995;109:1685-99.
27. Modrich P. Mismatch repair, genetic stability, and cancer. Science 1995;266:1959-60.
28. Leach F, Nicolaides N, Papadopoulos N, Liu B, Jen J, Parsons R, Sistonen P. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
29. Fishel R, Lescoe M, Rao M, Copeland N, Jenkins N, Garber J, Kane M. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
30. Papadopoulos N, Nicolaides N, Ruben S, Carter K, Rosen C, Fraser C. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
31. Bronner C, Baker S, Morrison P, Warren G, Smith L, Lecoe M, Lipford J. Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary nonpolyposis colon cancer. Nature 1994;368:258-61.
32. Nicolaides N, Papadopoulos N, Llu B, Carter K, Ruben S, Rosen C, Haseltine W, Fleischmann R. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
33. Parsons R, Li G-M, Longley M, Fang W, Papadopoulos N, Jen J, Kinzler K. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993;75:1227-36.
34. Liu B, Nicolaides N, Markowitz S, Willson J, Parsons R, Jen J, Hamilton S. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995;9:48-55.
35. Lazar V, Grandjouan S, Bognel C, Couturier D, Rougier P, Bellet D. Accumulation of multiple mutations in tumour suppressor genes during colorectal fumorigenesis in HNPCC patients. Hum Mol Genet 1994;3:2257-60.
36. Liu B, Hamilton S, Kinzler K. Polymerase and variants in RER colorectal tumours. Nat Genet 1995;9:10-1.
37. Papadopoulos N, Nicolaides N, Liu B, Parsons R, Lengauer C, Palombo F, Markowitz S. Mutations of GTBP in genetically unstable cells. Science 1995;268:1915-7.
38. Palombo F, Gallinari P, Laccarino I, Lettieri T, Hughes M, Truoin O, Hsuan J, Jirieny J. GTBP. A 160-Kilodalton protein essential for mismatch-binding activity in human cells. Science 1995;268:1912-4.
39. Correa P, Strong J, Reif A, Johnson W. The epidemiology of colorectal polyps. Prevalence in New Orleans and international comparisons. Cancer 1977;39:2258-64.
40. Berge T, Ekelund G, Meffner C, Phil B, Wenckert P. A carcinoma of the colon and rectum in a defined population. ACTA Chio Scand 1973;438:1-86.
41. Rickert R, Auerbach O, Garfinkel L, Frasca J. Adenomatous lesions of the large bowel: an autopsy survey. Cancer 1979;43:1847-57.
42. Williams A, Balasooriya B, Day D. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982;23:835-42.
43. Johnson D, Gurney M, Volpe R, Jones D, Choanian S, Avalos J, Buck J. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol 1990;85:969-74.
44. Lieberman D, Smith F. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991;86:946-51.
45. DiSario J, Fotch P, Mai H, Pardy K, Manne R. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol 1991;86:941-5.
46. Bazzoli F, Fossi S, Sottili S, Pozzato P, Zagari R, Morelli M, Taroni F, Roda E. The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastroenterology 1995;109:783-8.
47. Rex D, Lehman G, Hawes R, Ulbright T, Smith J. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991;100:64-7.
48. Rex D, Lehman G, Ulbright T, Smith J, Pound D, Hawes R, Helper D, Li W. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 1993;88:825-31.
49. Burt R, Bishop D, Cannon L, Dowdle M, Lee R, Skolnick M. Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 1985;312:1540-4.
50. Cannon-Albright L, Skolnick M, Bishop D, Lee R, Burt R. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med 1988;319:533-7.
51. Bonelli L, Marlines H, Conio M, Bruzzi P, Aste H. Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study. Int J Cancer 1988;41:513-7.
52. Baker J, Gathright J, Timmcke A, Hicks T, Ferrari B, Ray J. Colonoscopic screening of asymptomatic patients with a family history of colon cancer. Dis Colon Rectum 1990;33:926-30.
53. Guillem J, Forde K, Treat M, Neugut A, O'Toole K, Diamond B. Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. Dis Colon Rectum 1992;35:523-9.
54. Grossman S, Milos M, Tekawa I, Jewell N. Colonoscopic screening of persons with suspected risk factors for colon cancer: II. past history of colorectal neoplasms. Gastroenterology 1989;96:299-306.
55. Fuchs C, Giovannucci E, Colditz G, Hunter D, Speizer F, Willett W. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669-74.
56. Winawer S, Zauber A, Gerdes H, O'Brien M, Gottlieb L, Bond J, Waye J, Shike M, Kurtz R. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996;334:82-7.
57. Trock B, Lanza E, Greenwald P. Dietary fiber, vegetables, and colon cancer: Critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst 1990;82:650-61.
58. Wynder E, Reddy B, Weisburger J. Environmental dietary factors in colorectal cancer. Cancer 1992;70:1222-8.
59. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1987;66:1191-208.
60. Willett W, Stammpfer M, Colditz G, Rosner B, Speizer F. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990;323:1664-72.
61. Giovanucci E, Stampfer M, Colditz G, Rimm E. Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst 1992;84:91-6.
62. Vargas P, Alberts D. Primary prevention of colorectal cancer through dietary modification. Cancer 1992;70:1229-35.
63. Macrae F, MacLennan R, Ward M, Wahlqvist M, Ngu M. A randomized controlled trial of fat, fibre and betacarotene on colorectal adenomas. Gastroenterology 1995;108:A501.
64. Bremner C, Ackerman L. Polyps and carcinoma of the large bowel in the South African Bantu. Cancer 1970;26:991-9.
65. Bresalier R, Kim Y. Malignant neoplasms of the large intestine. Philadelphia: WB Saunders 1993;1449-93.
66. Winawer S, Schottenfeld D, Flehinger B. Colorectal cancer screening. J Natl Cancer Inst 1991;83:243-53.
67. Bond J. Polyp guideline: diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. Ann Intern Med 1993;119:836-43.
68. Toribara N, Sleisenger M. Screening for colorectal cancer. N Engl J Med 1995;332:861-85.
69. Winawer S, Flehinger B, Schottenfeld D, Miller D. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993;85:1311-8.
70. Mandel J, Bond J, Church T, Snover D, Bradley GM, Schuman L, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
71. Hardcastle J, Thomas W, Chamberlain J. Randomized controlled trial of fecal occult blood screening for colorectal cancer. Lancet 1989;1:1160-4.
72. Kewenter J, Bjork S, Haglund E. Screening and rescreening for colorectal cancer. Cancer 1988;62:645-51.
73. Kronborg O, Genger C, Worm J, Pedersen S, Jen J, Olsen J, Bertelsen K. Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1992;27:47-52.
74. Ahlquist D, Wieand H, Moertel C. Accuracy of fecal occult blood screening for colorectal neoplasia: A prospective study using hemoccult and hemo quant tests. JAMA 1993;269:1262-7.
75. Selby J, Friedman G, Quesenberry C, Weiss N. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
76. Newcomb P, Norfleet R, Storer B, Surawicz S, Marcus P. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1995;84:1572-5.
77. Gilbertsen V. Proctosigmoidoscopy and polypectomy in reducing the incidence of rectal cancer. Cancer 1974;34:936-9.
78. Atkin W, Morson B, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658-62.
79. Cuzick J, Atkin W, Northover J, Whynes D. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993;341:736-40.
80. Rex D, Lehman G, Ulbright T, Smith J, Hawes R. The yield of a second screening flexible sigmoidoscopy in average-risk persons after one negative examination. Gastroenterology 1994;106:593-5.
81. Winawer S, St. John D, Bond J, Rosen P, Burt R, Waye J, Kurtz R, Shike M. Prevention of colorectal cancer: guidelines based on new data. World Health Organization 1995;73:7-10.
82. Marra G, Boland C. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995;87:1114-25.
83. Aaltonen L, Peltomaki P, Mecklin J-P, Jarvinen H, Jass J, Green J, Lynch H, Watson P. Replication erors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994;54:1645-8.
84. Peltomaki P, Loeb L, Liu B, Wooster R, Bisgaard M, Lothe R, Ionov Y. Microsatellite instability as an indicator of hereditary susceptibility to colon cancer. Gastroenterology 1995;109:2031-3.
85. Liu B, Farrington S, Petersen G, Hamilton S, Parsons R, Jen J, Wyllie A, Kinzler K, Dunlop M. Genetic instability occurs in the majority of young patients with colorectal cancer. Nature Med 1995;1:348-52.
86. Jarvinen H, Mecklin J-P, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.
87. Vasen H, Mecklin J-P, Watson P, Utsunomiya J, Bertario L, Lynch P, Svendsen L, Muller H. Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. Dis Colon Rectum 1993;36:1-4.
88. Luce M, Marra G, Chauhan D, Laghi L, Carethers J, Cherian S, Hawn M, Koi M, Binnie C. In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 1995;109:1368-74.
89. Nystrom-Lahti M, Kristo P, Nicolaides N, Chang L, Aaltonen A, Moisio A, Jarvinen H, Mecklin J, Kinzler K, Vogelstein B, De La Chapelle A, Peltomaki P. Founding mutations and alu-mediated recombination in hereditary colon cancer. Nature Medicine 1995;1:1203-6.
90. Hamilton S, Liu B, Parsons R, Papadopoulos N, Jen J, Powell S, Krush A, Cohen Z, Buger P. The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839-47.
91. Bisgaard M, Fenger I, Bulow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994;3:121-5.
92. Bertoni G, Sassatelli R, Nigrisoli E, Tansini P, Roncucci L, Bedogni G. First observation of microadenomas in the lleal mucosa of patients with familial adenomatous polyposis and colectomies. Gastroenterology 1995;109:374-80.
93. Powell S, Petersen G, Krush A, Booker S, Jen J, Giardiello F, Hamilton S, Vogelstein B. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993;329:1982-7.
94. Winawer S, Zauber A, O'Brien M, Gottlieb L, Sternberg S, Waye J, Bond J, Shike M, Kurtz R. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993;328:901-6.
95. Neugut A, Jacobson J, Ahsan H, Santos J, Garowski G, Forde K, Treat M, Waye J. Incidence and recurrence rates of colorectal adenomas: a prospective study. Gastroenterology 1995;108:402-8.
96. Luk GD. Cancer surveillance strategies. In: Sleisenger MH FJ, ed. Gastrointestinal Disease. Philadelphia: WB Saunders, 1993:115-26.
97. Nugent F, Haggitt R, Gilpin P. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241-8.
98. Sachar D, Greenstein A, Burmner G, Nystrom L, Choi P. Clinical and colonoscopic surveillance in ulcerative colitis: are we saving colons or saving lives? Gastroenterology 1993; 105:588-97.
99. Lennard-Jones J. Colitic cancer: supervision, surveillance, or surgery. Gastroenterology 1995;109:1388-91.
100. Choi P, Nugent F, Schoetz D, Silverman M, Haggit R. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105:418-24.
101. Connell W, Lennard J, Williams C, Talbot I, Price A, Wilkinson K. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
102. Rozen P, Baratz M, Fefer F, Gilat T. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 1995;108:1361-70.
103. Brentnall T, Rubin C, Crispin D, Stevens A, Batchelor R, Haggitt R, Bronner M. A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology 1995;109:151-5.
104. Sidransky D, Tokino T, Hamilton S, Frost P, Vogelstein B, Kinzler K, Levin B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256:102-5.